JHancock Classic Value C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
John Hancock Classic Value Fund Class C JCVCX
- NAV / 1-Day Return 19.96 / −2.00 %
- Total Assets 525.7M
-
Adj. Expense Ratio
1.860%
- Expense Ratio 1.890%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Mid-Cap Value
- Investment Style Mid Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.15%
- Turnover 13%
USD | NAV as of Jun 17, 2026 | 1-Day Return as of Jun 17, 2026, 10:13 PM GMT+0
Morningstar’s Analysis JCVCX
Will JCVCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the JCVCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of JCVCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
CVS Health Corp | 5.44 | 27M | Healthcare |
Humana Inc | 5.42 | 27M | Healthcare |
Baxter International Inc | 4.87 | 24M | Healthcare |
Skyworks Solutions Inc | 4.28 | 21M | Technology |
Fresenius Medical Care AG ADR | 3.96 | 20M | Healthcare |
Citigroup Inc | 3.90 | 19M | Financial Services |
Magna International Inc | 3.64 | 18M | Consumer Cyclical |
MetLife Inc | 3.61 | 18M | Financial Services |
Wells Fargo & Co | 3.58 | 18M | Financial Services |
Corebridge Financial Inc | 3.46 | 17M | Financial Services |
United States